Truist Securities Reiterates Buy Rating on CVS Health (CVS) Amid CFO Transition
Tweet Send to a Friend
Truist Securities analyst David MacDonald reiterated a Buy rating and $76.00 price target on CVS Health (NYSE: CVS).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
